Speech Therapy for a Child with Neurosarcoidosis: A Case Report

Document Type : Case Reports


1 PhD Candidate, Department of Speech Therapy, School of Rehabilitation Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 MSc, Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

3 PhD Candidate, Health Information Technology Research Center, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran



Introduction: Sarcoidosis is a multisystem granulomatous disorder with an unidentified origin. The prevalence of sarcoidosis in children is rare and also its frequency is unknown. There is some evidence of central nervous system (CNS) involvement in patients with sarcoidosis. The effect of rehabilitation, especially speech therapy, in these patients has not been reported before. This study reported the speech and language characteristics of a child with neurosarcoidosis before, during, and after speech therapy by formal and informal speech and language assessments.
Case Report: The case was a 4-year-old boy with neurosarcoidosis. The language comprehension and expression skills of the child were delayed and weak in comparison to their normal peers. During speech therapy, the child's language comprehension and expression skills were improving, which might indicate the effectiveness of speech therapy. The improvements in the child's language abilities were seen only during speech therapy, while after speech therapy, his language skills, speech intelligibility, and verbal output showed deterioration to some extent. Unfortunately, not only the improvement of the child's language was not maintained after the speech therapy, but also this decline was associated with the peak of the child's disease.
Conclusion: To conclude, more studies are needed about the time of providing speech therapy and its dose in children with neurosarcoidosis at different phases of disease progression.


Main Subjects

  1. Burns TM. Neurosarcoidosis. Arch Neurol 2003; 60(8): 1166-8.
  2. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet 2014; 383(9923): 1155-67.
  3. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145(3): 234-41.
  4. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31(2): 372-9.
  5. Anantham D, Ong SJ, Chuah KL, Fook-Chong S, Hsu A, Eng P. Sarcoidosis in Singapore: epidemiology, clinical presentation and ethnic differences. Respirology 2007; 12(3): 355-60.
  6. Rao R, Dimitriades VR, Weimer M, Sandlin C. Neurosarcoidosis in pediatric patients: A case report and review of isolated and systemic neurosarcoidosis. Pediatr Neurol 2016; 63: 45-52.
  7. Wang F, Guo D, Liu Z, Zhou A, Wei C, Jia J. Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients. Neurol Sci 2018; 39(10): 1725-33.
  8. Taous A, Berri MA, Sinaa M, En-Nafaa I, Nadour K, Rouimi A. An unusual presentation of neurosarcoidosis with progressive hearing loss. Pan Afr Med J 2017; 28: 213.
  9. Ugurlu S, Murt A, Seyahi E, Uygunoglu U, Saip S, Ozdogan H. A case of neurosarcoidosis with aggresive characteristics. Pediatr Rheumatol Online J. 2014; 12(Suppl 1): P289.
  10. Mousavi SZ, Mehri A, Nabavi D, Faraji M, Maroufizadeh S. Comparing the diadochokinetic rate in Farsi-speaking young and older adults. Iran Rehabil J 2020; 18(1): 57-64. [In Persian].
  11. Ahmadi A, Ebadi A, Kamali M, Zarifian T, Dastjerdi Kazemi M, Mohamadi R. Single word test for the assessment of speech sound production in Persian speaking children: Development, validity and reliability. Int J Pediatr Otorhinolaryngol 2018; 114: 61-6.
  12. Paul R, Norbury C. language disorders from infancy through adolescence: Listening, speaking, reading, writing, and communicating. St Louis, MO: Elsevier Mosby; 2012.
  13. Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive care for patients with sarcoidosis. J Clin Med 2020; 9(2): 390.
  14. Kolb B, Gibb R. Brain plasticity and behaviour in the developing brain. J Can Acad Child Adolesc Psychiatry 2011; 20(4): 265-76.